tyloxapol has been researched along with n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, H; Ishikawa, E; Itokawa, S; Odaka, H; Sugiyama, Y; Tomari, Y | 1 |
1 other study(ies) available for tyloxapol and n-(4-(2-chlorophenyl)-6,7-dimethyl-3-quinolyl)-n'-(2,4-difluorophenyl)urea
Article | Year |
---|---|
TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
Topics: Animals; Anticholesteremic Agents; Cells, Cultured; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Dose-Response Relationship, Drug; Esterification; Intestinal Absorption; Liver; Lovastatin; Male; Mesocricetus; Phenylurea Compounds; Polyethylene Glycols; Sterol O-Acyltransferase | 1995 |